Rankings
▼
Calendar
IMUX Q2 2017 Earnings — Immunic, Inc. Revenue & Financial Results | Market Cap Arena
IMUX
Immunic, Inc.
$138M
Q2 2017 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$13M
Net Income
-$12M
EPS (Diluted)
$-11.76
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$10M
Free Cash Flow
-$10M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$81M
Total Liabilities
$7M
Stockholders' Equity
$73M
Cash & Equivalents
$76M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$13M
-$10M
-31.5%
Net Income
-$12M
-$9M
-31.0%
← FY 2017
All Quarters
Q3 2017 →